v3.26.3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
REVENUE $ 647 $ 388 $ 1,646 $ 730
COST OF GOODS SOLD 122 242 647 267
GROSS PROFIT 525 146 999 463
OPERATING EXPENSES:        
Research and development expenses 383 378 1,332 1,026
Selling and marketing expenses 194 265 515 672
General and administration expenses 1,490 2,007 4,678 4,968
Impairment of intangible asset 0 152 0 152
TOTAL OPERATING EXPENSES 2,067 2,802 6,525 6,818
OPERATING LOSS (1,542) (2,656) (5,526) (6,355)
OTHER INCOME (EXPENSE)        
Interest and bank fees (4) (10) (17) (153)
Interest income 68 29 123 59
Unrealized gain (loss) on foreign exchange (1) 0 (2) (4)
Change in derivative fair value 0 0 0 (9,369)
Loss on settlement 0 0 0 (1,353)
Other income (expense), net 0 (2) (45) (223)
TOTAL OTHER INCOME (EXPENSE) 63 17 59 (11,043)
LOSS BEFORE INCOME TAX (1,479) (2,639) (5,467) (17,398)
Income tax provision 0 0 0 4
NET LOSS AND COMPREHENSIVE LOSS (1,479) (2,639) (5,467) (17,402)
Deemed dividend on warrant inducement 0 0 90 4,410
NET LOSS AND COMPREHENSIVE LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (1,479) $ (2,639) $ (5,557) $ (21,812)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.07) $ (0.2) $ (0.29) $ (1.81)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 21,555,238 13,497,668 18,990,405 12,054,020